Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CXCL16 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | TSPAN6 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | SNAP25 | CCLE | pan-cancer | AAC | -0.19 | 0.0002 |
mRNA | OPN3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ALDH9A1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | HES1 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
mRNA | GPKOW | CCLE | pan-cancer | AAC | -0.17 | 0.0002 |
mRNA | CDK5RAP2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | EPN3 | CCLE | pan-cancer | AAC | 0.21 | 0.0002 |
mRNA | LPAR2 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |